Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis

Conclusions Pazopanib is an active treatment in DT/AF. It is the first time this has been reported.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research